To my way of thinking, at this stage funding sufficient until H2/20 therefore
Immutep will want something in place by years end otherwise a CR or other
will need to be announced by end of Jan 2020 to ensure funds are available
for 3rd quarter......There's a lot of data due before then though, such measures
may not be needed...Also see another addition to company calendar...
Clinical pipeline/website..., page-3
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.3¢ |
Change
0.008(2.63%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 29.0¢ | $142.8K | 490.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 24171 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 135412 | 18 |
View Market Depth
| Last trade - 10.18am 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
